FDA gave green signal to Sanofi's Aubagio drug
After a series of failure to get many of its drugs get patent protection, Sanofi SA has finally tasted success. Its multiple sclerosis drug known as Aubagio has got green signal from the US regulators.

Once the drug becomes popular it is regarded to act as a highest gainer for Sanofi and it's going to act as a highly competitive drug for the existing effective drugs. As per the industry experts, the MS clinical market is around $12 billion on a yearly basis.
This teriflunomide is a once daily tablet that has been approved as an effective medication for treatment of the initial phase of the detrimental MS disease.
MS as we all know is a long-term autoimmune disease of Central nervous system that also causes inflammation of the brain along with disrupting the communication between the brain and other body parts.
Individuals with MS are found to have episodes of relapses (those results in worsening of the condition) which in turn are followed by remissions (recovery).
The side effects that were reported by the drug are hair loss, diarrhea, nausea, abnormal liver test, etc. and hence, it is regarded to be taken only after consultation with your medical professional.
The precautionary measures that should be followed include avoiding the drug in case you suffer from any delirious clinical conditions of the liver, in case you are a pregnant woman, etc.
Also, stay away from it as it is found to cause birth \defects in some cases and may also prove fatal in some extreme cases.
For More information please visit our site : http://www.xmaspharmacy.com/
###
Categories: Health
Press Release Contact
Xmaspharmacy
4th Lane, Stockton, California
95204, USA
http://www.xmaspharmacy.com/
Xmaspharmacy
4th Lane, Stockton, California
95204, USA
http://www.xmaspharmacy.com/